 | • レポートコード：MRC23Q38196 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の医薬品用滅菌注射剤市場について調査・分析し、世界の医薬品用滅菌注射剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（高分子医薬品滅菌注射剤、低分子医薬品滅菌注射剤）、用途別セグメント分析（がん、糖尿病、循環器疾患、中枢神経系、感染症、筋骨格）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Baxter International Inc、AstraZeneca plc、Merck & Co., Inc、Novartis AG、Johnson & Johnson Services, Incなどが含まれています。 世界の医薬品用滅菌注射剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、医薬品用滅菌注射剤市場規模を推定する際に考慮しました。本レポートは、医薬品用滅菌注射剤の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、医薬品用滅菌注射剤に関するビジネス上の意思決定に役立てることを目的としています。 ・医薬品用滅菌注射剤市場の概要 - 製品の定義 - 医薬品用滅菌注射剤のタイプ別セグメント - 世界の医薬品用滅菌注射剤市場規模：タイプ別分析（高分子医薬品滅菌注射剤、低分子医薬品滅菌注射剤） - 医薬品用滅菌注射剤の用途別セグメント - 世界の医薬品用滅菌注射剤市場規模：用途別分析（がん、糖尿病、循環器疾患、中枢神経系、感染症、筋骨格） - 世界の医薬品用滅菌注射剤市場規模予測（2018年-2029年） - 医薬品用滅菌注射剤の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 医薬品用滅菌注射剤市場の競争状況およびトレンド ・医薬品用滅菌注射剤の地域別市場規模 - 北米の医薬品用滅菌注射剤市場規模（2018年-2029年） - アメリカの医薬品用滅菌注射剤市場規模（2018年-2029年） - ヨーロッパの医薬品用滅菌注射剤市場規模（2018年-2029年） - アジア太平洋の医薬品用滅菌注射剤市場規模（2018年-2029年） - 中国の医薬品用滅菌注射剤市場規模（2018年-2029年） - 日本の医薬品用滅菌注射剤市場規模（2018年-2029年） - 韓国の医薬品用滅菌注射剤市場規模（2018年-2029年） - インドの医薬品用滅菌注射剤市場規模（2018年-2029年） - オーストラリアの医薬品用滅菌注射剤市場規模（2018年-2029年） - 中南米の医薬品用滅菌注射剤市場規模（2018年-2029年） - 中東・アフリカの医薬品用滅菌注射剤市場規模（2018年-2029年） ・タイプ別セグメント：高分子医薬品滅菌注射剤、低分子医薬品滅菌注射剤 - 世界の医薬品用滅菌注射剤のタイプ別販売量（2018年-2023年） - 世界の医薬品用滅菌注射剤のタイプ別売上（2018年-2023年） - 世界の医薬品用滅菌注射剤のタイプ別価格 ・用途別セグメント：がん、糖尿病、循環器疾患、中枢神経系、感染症、筋骨格 - 世界の医薬品用滅菌注射剤の用途別販売量（2018年-2023年） - 世界の医薬品用滅菌注射剤の用途別売上（2018年-2023年） - 世界の医薬品用滅菌注射剤の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Baxter International Inc、AstraZeneca plc、Merck & Co., Inc、Novartis AG、Johnson & Johnson Services, Inc ・産業チェーンと販売チャネルの分析 - 医薬品用滅菌注射剤産業チェーン分析 - 医薬品用滅菌注射剤の主要原材料 - 医薬品用滅菌注射剤の販売チャネル - 医薬品用滅菌注射剤のディストリビューター - 医薬品用滅菌注射剤の主要顧客 ・医薬品用滅菌注射剤市場ダイナミクス - 医薬品用滅菌注射剤の業界動向 - 医薬品用滅菌注射剤市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Pharmaceutical Sterile Injectables market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Pharmaceutical Sterile Injectables is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pharmaceutical Sterile Injectables is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Pharmaceutical Sterile Injectables include Baxter International Inc, AstraZeneca plc, Merck & Co., Inc, Novartis AG and Johnson & Johnson Services, Inc, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Sterile Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Sterile Injectables.
The Pharmaceutical Sterile Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharmaceutical Sterile Injectables market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Sterile Injectables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Baxter International Inc
AstraZeneca plc
Merck & Co., Inc
Novartis AG
Johnson & Johnson Services, Inc
Segment by Type
Large Molecules Pharmaceutical Sterile Injectables
Small Molecules Pharmaceutical Sterile Injectables
Segment by Application
Cancer
Diabetes
Cardiovascular Diseases
Central Nervous Systems
Infectious Disorders
Musculoskeletal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Sterile Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Sterile Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pharmaceutical Sterile Injectables Market Overview
1.1 Product Overview and Scope of Pharmaceutical Sterile Injectables
1.2 Pharmaceutical Sterile Injectables Segment by Type
1.2.1 Global Pharmaceutical Sterile Injectables Market Value Comparison by Type (2023-2029)
1.2.2 Large Molecules Pharmaceutical Sterile Injectables
1.2.3 Small Molecules Pharmaceutical Sterile Injectables
1.3 Pharmaceutical Sterile Injectables Segment by Application
1.3.1 Global Pharmaceutical Sterile Injectables Market Value by Application: (2023-2029)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Central Nervous Systems
1.3.6 Infectious Disorders
1.3.7 Musculoskeletal
1.4 Global Pharmaceutical Sterile Injectables Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Sterile Injectables Revenue 2018-2029
1.4.2 Global Pharmaceutical Sterile Injectables Sales 2018-2029
1.4.3 Global Pharmaceutical Sterile Injectables Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pharmaceutical Sterile Injectables Market Competition by Manufacturers
2.1 Global Pharmaceutical Sterile Injectables Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pharmaceutical Sterile Injectables Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pharmaceutical Sterile Injectables Average Price by Manufacturers (2018-2023)
2.4 Global Pharmaceutical Sterile Injectables Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pharmaceutical Sterile Injectables, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Sterile Injectables, Product Type & Application
2.7 Pharmaceutical Sterile Injectables Market Competitive Situation and Trends
2.7.1 Pharmaceutical Sterile Injectables Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Sterile Injectables Players Market Share by Revenue
2.7.3 Global Pharmaceutical Sterile Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Sterile Injectables Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Sterile Injectables Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pharmaceutical Sterile Injectables Global Pharmaceutical Sterile Injectables Sales by Region: 2018-2029
3.2.1 Global Pharmaceutical Sterile Injectables Sales by Region: 2018-2023
3.2.2 Global Pharmaceutical Sterile Injectables Sales by Region: 2024-2029
3.3 Global Pharmaceutical Sterile Injectables Global Pharmaceutical Sterile Injectables Revenue by Region: 2018-2029
3.3.1 Global Pharmaceutical Sterile Injectables Revenue by Region: 2018-2023
3.3.2 Global Pharmaceutical Sterile Injectables Revenue by Region: 2024-2029
3.4 North America Pharmaceutical Sterile Injectables Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Sterile Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pharmaceutical Sterile Injectables Sales by Country (2018-2029)
3.4.3 North America Pharmaceutical Sterile Injectables Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pharmaceutical Sterile Injectables Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Sterile Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pharmaceutical Sterile Injectables Sales by Country (2018-2029)
3.5.3 Europe Pharmaceutical Sterile Injectables Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Sterile Injectables Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Sterile Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pharmaceutical Sterile Injectables Sales by Country (2018-2029)
3.6.3 Asia Pacific Pharmaceutical Sterile Injectables Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pharmaceutical Sterile Injectables Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Sterile Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pharmaceutical Sterile Injectables Sales by Country (2018-2029)
3.7.3 Latin America Pharmaceutical Sterile Injectables Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Sterile Injectables Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Sterile Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pharmaceutical Sterile Injectables Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pharmaceutical Sterile Injectables Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pharmaceutical Sterile Injectables Sales by Type (2018-2029)
4.1.1 Global Pharmaceutical Sterile Injectables Sales by Type (2018-2023)
4.1.2 Global Pharmaceutical Sterile Injectables Sales by Type (2024-2029)
4.1.3 Global Pharmaceutical Sterile Injectables Sales Market Share by Type (2018-2029)
4.2 Global Pharmaceutical Sterile Injectables Revenue by Type (2018-2029)
4.2.1 Global Pharmaceutical Sterile Injectables Revenue by Type (2018-2023)
4.2.2 Global Pharmaceutical Sterile Injectables Revenue by Type (2024-2029)
4.2.3 Global Pharmaceutical Sterile Injectables Revenue Market Share by Type (2018-2029)
4.3 Global Pharmaceutical Sterile Injectables Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pharmaceutical Sterile Injectables Sales by Application (2018-2029)
5.1.1 Global Pharmaceutical Sterile Injectables Sales by Application (2018-2023)
5.1.2 Global Pharmaceutical Sterile Injectables Sales by Application (2024-2029)
5.1.3 Global Pharmaceutical Sterile Injectables Sales Market Share by Application (2018-2029)
5.2 Global Pharmaceutical Sterile Injectables Revenue by Application (2018-2029)
5.2.1 Global Pharmaceutical Sterile Injectables Revenue by Application (2018-2023)
5.2.2 Global Pharmaceutical Sterile Injectables Revenue by Application (2024-2029)
5.2.3 Global Pharmaceutical Sterile Injectables Revenue Market Share by Application (2018-2029)
5.3 Global Pharmaceutical Sterile Injectables Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Baxter International Inc
6.1.1 Baxter International Inc Corporation Information
6.1.2 Baxter International Inc Description and Business Overview
6.1.3 Baxter International Inc Pharmaceutical Sterile Injectables Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter International Inc Pharmaceutical Sterile Injectables Product Portfolio
6.1.5 Baxter International Inc Recent Developments/Updates
6.2 AstraZeneca plc
6.2.1 AstraZeneca plc Corporation Information
6.2.2 AstraZeneca plc Description and Business Overview
6.2.3 AstraZeneca plc Pharmaceutical Sterile Injectables Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca plc Pharmaceutical Sterile Injectables Product Portfolio
6.2.5 AstraZeneca plc Recent Developments/Updates
6.3 Merck & Co., Inc
6.3.1 Merck & Co., Inc Corporation Information
6.3.2 Merck & Co., Inc Description and Business Overview
6.3.3 Merck & Co., Inc Pharmaceutical Sterile Injectables Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck & Co., Inc Pharmaceutical Sterile Injectables Product Portfolio
6.3.5 Merck & Co., Inc Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Pharmaceutical Sterile Injectables Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Pharmaceutical Sterile Injectables Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Johnson & Johnson Services, Inc
6.5.1 Johnson & Johnson Services, Inc Corporation Information
6.5.2 Johnson & Johnson Services, Inc Description and Business Overview
6.5.3 Johnson & Johnson Services, Inc Pharmaceutical Sterile Injectables Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johnson & Johnson Services, Inc Pharmaceutical Sterile Injectables Product Portfolio
6.5.5 Johnson & Johnson Services, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Sterile Injectables Industry Chain Analysis
7.2 Pharmaceutical Sterile Injectables Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Sterile Injectables Production Mode & Process
7.4 Pharmaceutical Sterile Injectables Sales and Marketing
7.4.1 Pharmaceutical Sterile Injectables Sales Channels
7.4.2 Pharmaceutical Sterile Injectables Distributors
7.5 Pharmaceutical Sterile Injectables Customers
8 Pharmaceutical Sterile Injectables Market Dynamics
8.1 Pharmaceutical Sterile Injectables Industry Trends
8.2 Pharmaceutical Sterile Injectables Market Drivers
8.3 Pharmaceutical Sterile Injectables Market Challenges
8.4 Pharmaceutical Sterile Injectables Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer